Blueshift Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,984
Closed -$37.9K 548
2025
Q4
$37.9K Buy
+13,984
New +$45.9K 0.01% 437
2023
Q1
Sell
-57,349
Closed -$267K 378
2022
Q4
$267K Sell
57,349
-49,842
-46% -$246K 0.12% 248
2022
Q3
$501K Buy
+107,191
New +$676K 0.11% 279
2022
Q1
Sell
-7,015
Closed -$229K 942
2021
Q4
$229K Buy
+7,015
New +$282K 0.02% 718
2021
Q1
Sell
-12,028
Closed -$485K 929
2020
Q4
$485K Buy
+12,028
New +$553K 0.06% 412

Other funds holding GDRX

Blueshift Asset Management's GDRX Position: Q1 2026 in Review

Blueshift Asset Management sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 13,984 shares — an estimated $37.9K sold.

Blueshift Asset Management first reported a position in GDRX in Q4 2020 and held it in 5 quarters. The position peaked at $501K in Q3 2022. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Blueshift Asset Management reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Blueshift Asset Management sold 13,984 GoodRx Holdings shares in Q1 2026, an estimated $37.9K.
  • Blueshift Asset Management first reported a position in GoodRx Holdings in Q4 2020 and held it in 5 quarters.
  • Blueshift Asset Management's GoodRx Holdings position peaked at $501K in Q3 2022.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Blueshift Asset Management's 13F filing for Q1 2026, filed 14 May 2026.